1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThe Biomedical Catalyst is a flagship funding mechanism designed to support innovative health and care solutions across life sciences, including therapeutics, medical devices, and digital health.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: UK-registered SMEs with innovative health and care technologies. Projects can range from market and technology feasibility studies (Accelerator) to larger industrial research and development, and investor partnerships. Confirm the full requirements in the official notice before applying.
The current listing shows £50,000 - £4 million (project cost, with varying grant funding). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Biomedical Catalyst is funded by Innovate UK (part of UKRI) and Medical Research Council (MRC). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleThe RUS Powering Affordable Reliable Technology (PART) Energy Program takes Letters of Interest until October 9, 2026. Up to 40% of each loan can be forgiven, awards run $1M to $100M, and USDA describes eligible generation as hydro, geothermal, and biomass — even though Section 317 of the RE Act names solar and wind.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read article